New liquid form of maribavir tested in healthy adults
NCT ID NCT04131556
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study tested two liquid versions of the drug maribavir (used to treat certain viral infections) to see how well they are absorbed, how they taste, and if they are safe compared to the current tablet. The study involved 20 healthy adults, not children, to gather initial data. The goal is to eventually develop a child-friendly formulation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- maribavir
- What this could lead to
- If successful, this could lead to a child-friendly liquid version of maribavir, making it easier to give to children who need it.
- What could go wrong
- This is a very early (Phase 1) study in only 20 healthy adults, not children. The liquid formulations may not work as well or taste acceptable, and the study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Pharmacology of Miami, Llc
Miami, Florida, 33014, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults